Florida Cancer Specialists NORTH - SCRI - PPDS — St. Petersburg, Florida

Florida Cancer Specialists NORTH - SCRI - PPDS is a clinical research site located in St. Petersburg, Florida, United States 33705.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Florida Cancer Specialists NORTH - SCRI - PPDS has participated in 8 clinical trials with 3 currently active.

Therapeutic areas: Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.

Sponsors: Takeda, Genentech, Inc., Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in St. Petersburg

Browse all research sites in Florida · View every site in St. Petersburg

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Florida Cancer Specialists NORTH - SCRI - PPDS?

Florida Cancer Specialists NORTH - SCRI - PPDS has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Florida Cancer Specialists NORTH - SCRI - PPDS conducted?

Florida Cancer Specialists NORTH - SCRI - PPDS has 8 clinical trials on record, with 3 currently active. Their work covers Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.

Is Florida Cancer Specialists NORTH - SCRI - PPDS accredited by Crixeo Clinical Trials?

Florida Cancer Specialists NORTH - SCRI - PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Florida Cancer Specialists NORTH - SCRI - PPDS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.